PSCR (Proto Script Pharmaceutical) Other Stockholders Equity: $0.00 Mil (As of Sep. 2017)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Proto Script Pharmaceutical Other Stockholders Equity?

Proto Script Pharmaceutical PSCR Other Stockholders Equity is $0.00 Mil as of Sep. 2017.

Proto Script Pharmaceutical's Other Stockholders Equity for the quarter that ended in Sep. 2017 was $0.00 Mil.

Proto Script Pharmaceutical's quarterly Other Stockholders Equity increased from Mar. 2017 ($-0.00 Mil) to Jun. 2017 ($-0.00 Mil) and increased from Jun. 2017 ($-0.00 Mil) to Sep. 2017 ($0.00 Mil).

Proto Script Pharmaceutical's annual Other Stockholders Equity increased from May. 2014 ($-0.00 Mil) to May. 2015 ($0.00 Mil) but then stayed the same from May. 2015 ($0.00 Mil) to May. 2016 ($0.00 Mil).

Proto Script Pharmaceutical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Proto Script Pharmaceutical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proto Script Pharmaceutical Other Stockholders Equity Chart

Proto Script Pharmaceutical Annual Data
Trend May12 May13 May14 May15 May16
Other Stockholders Equity
-0.00 0.00 -0.00 0.00 0.00

Proto Script Pharmaceutical Quarterly Data
Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15 Aug15 Nov15 Feb16 May16 Sep16 Dec16 Mar17 Jun17 Sep17
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.00 -0.00 -0.00 0.00

Proto Script Pharmaceutical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.00 Mil mean?
Proto Script Pharmaceutical (PSCR) has a Other Stockholders Equity of $0.00 Mil as of Sep. 2017. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Proto Script Pharmaceutical and its competitors.
Is Proto Script Pharmaceutical's Other Stockholders Equity too high?
Proto Script Pharmaceutical's current Other Stockholders Equity is $0.00 Mil.
How does Proto Script Pharmaceutical's Other Stockholders Equity compare to EXCC and NXES?
Proto Script Pharmaceutical's Other Stockholders Equity of $0.00 Mil can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Business Services company?
A good Other Stockholders Equity depends on the Business Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Proto Script Pharmaceutical and its competitors. Proto Script Pharmaceutical's current Other Stockholders Equity is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proto Script Pharmaceutical stock overvalued right now?
Proto Script Pharmaceutical (PSCR) has a current Other Stockholders Equity of $0.00 Mil. The current Other Stockholders Equity is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Proto Script Pharmaceutical (PSCR), the current Other Stockholders Equity is $0.00 Mil as of Sep. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proto Script Pharmaceutical Business Description

Address 9830 6th Street, Suite 103, Rancho Cucamonga, CA, USA, 91730
Proto Script Pharmaceutical Corp is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. It has various contracts with state and governmental insurance providers, among others. These contracts provide the company with the right to sell and repair DME and its health care insurance contracts allow it the ability to service patients nationally. The group currently has its presence of repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California.